Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements. The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank objectives of cash flow statement #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer.
The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks.
Since then, VREX stock has decreased by 7.9% and is now trading at $18.70. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams.
And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. VREX’s beta can be found in Trading Information at the top of this page. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. A replay of the presentation will be available on Varex’s website at /news. The replay will be available for 90 days after the presentation.
These returns cover a period from January 1, 1988 through July 31, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends https://1investing.in/ received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return.
Varex Imaging Corp
Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Varex Imaging Corp designs and manufactures X-ray imaging components. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
Varex Announces Financial Results for First Quarter Fiscal Year 2022
The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s.
There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. One share of VREX stock can currently be purchased for approximately $18.70. Varex Imaging’s stock was trading at $20.30 at the beginning of 2023.
- A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return.
- Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components.
- It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia.
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. This site is protected by reCAPTCHA and the Google
Terms of Service apply. We’d like to share more about how we work and what drives our day-to-day business. Compare
VREX’s historical performance
against its industry peers and the overall market.
Research & Ratings Varex Imaging Corp.(VREX)
On average, they expect the company’s share price to reach $33.00 in the next year. This suggests a possible upside of 76.5% from the stock’s current price. View analysts price targets for VREX or view top-rated stocks among Wall Street analysts.
Varex Imaging issued an update on its fourth quarter 2023 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of $0.20-$0.40 for the period, compared to the consensus earnings per share estimate of $0.38. The company issued revenue guidance of $220.00 million-$240.00 million, compared to the consensus revenue estimate of $235.77 million. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.32% per year.
Price Target and Rating
It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world. Analysts like Varex Imaging less than other Medical companies. The consensus rating score for Varex Imaging is 2.50 while the average consensus rating score for medical companies is 2.65. According to 2 analysts, the average rating for VREX stock is “Buy.” The 12-month stock price forecast is $33.0, which is an increase of 75.11% from the latest price.
2 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Varex Imaging in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should “moderate buy” VREX shares.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated. Varex Imaging’s stock is owned by many different institutional and retail investors. Insiders that own company stock include Jay K Kunkel, Kimberley E Honeysett, Ruediger Naumann-Etienne and Sunny Sanyal. The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 21st 2023.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The scores are based on the trading styles of Value, Growth, and Momentum.
Sign-up to receive the latest news and ratings for VREX and its competitors with MarketBeat’s FREE daily newsletter. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Sign-up to receive the latest news and ratings for Varex Imaging and its competitors with MarketBeat’s FREE daily newsletter. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.
Varex Imaging Corp. VREX (U.S.: Nasdaq)
With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate Varex’s X-ray sources, digital detectors, connecting devices and imaging software in their systems to detect, diagnose, protect and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,400 people located in North America, Europe, and Asia. 2 Wall Street research analysts have issued 1 year price objectives for Varex Imaging’s stock. Their VREX share price forecasts range from $24.00 to $42.00.
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah. Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems.
Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in 2016 and is headquartered in Salt Lake City, UT. According to the issued ratings of 2 analysts in the last year, the consensus rating for Varex Imaging stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for VREX. The average twelve-month price prediction for Varex Imaging is $33.00 with a high price target of $42.00 and a low price target of $24.00.